Literature DB >> 9268501

FLT3 ligand induces the generation of functionally active dendritic cells in mice.

M R Shurin1, P P Pandharipande, T D Zorina, C Haluszczak, V M Subbotin, O Hunter, A Brumfield, W J Storkus, E Maraskovsky, M T Lotze.   

Abstract

FLT3 ligand (FL) is a recently described hematopoietic growth factor that stimulates the proliferation and differentiation of hematopoietic progenitors. We have investigated the effect of FL on murine hematopoiesis and dendritic cell (DC) generation and accumulation in lymphoid tissues and liver in vivo and in vitro evaluating the morphologic, phenotypic, and functional characteristics of these DC. We have observed extramedullary hematopoiesis in the mouse spleen with all lineages of hematopoietic cells represented after the administration of FL. Injection of FL results in a time-dependent and reversible accumulation of DC in the spleen, bone marrow, lymph nodes, and liver. Both flow cytometry and immunohistochemistry revealed a significant accumulation of DC in these tissues. Results of mixed leukocyte reaction suggested that these cells, isolated from murine bone marrow or spleen, were active as antigen presenting cells. Furthermore, cultivation of splenic and marrow cells with GM-CSF and IL-4 gave rise to large numbers of functionally active mature DC. Thus, the results of this study suggest that FL is a promising growth factor that stimulates the generation of large number of DC and may be a useful cytokine for the immunotherapy of cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268501     DOI: 10.1006/cimm.1997.1152

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  39 in total

Review 1.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists.

Authors:  Christopher W Cutler; Yen-Tung A Teng
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

3.  Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice.

Authors:  I B Kremer; M P Gould; K D Cooper; F P Heinzel
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.

Authors:  Hua Zhong; Dmitriy W Gutkin; Baohui Han; Yang Ma; Anton A Keskinov; Michael R Shurin; Galina V Shurin
Journal:  Int J Cancer       Date:  2014-01-20       Impact factor: 7.396

5.  Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant.

Authors:  Douglas G McNeel; Keith L Knutson; Kathy Schiffman; Donna R Davis; Dania Caron; Mary L Disis
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

6.  Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth.

Authors:  Hua Zhong; Baohui Han; Irina L Tourkova; Anna Lokshin; Alan Rosenbloom; Michael R Shurin; Galina V Shurin
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

7.  Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques.

Authors:  R Keith Reeves; Qing Wei; Jackie Stallworth; Patricia N Fultz
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

8.  Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.

Authors:  Harry Matundan; Kevin R Mott; Homayon Ghiasi
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  Phenotypic and functional abnormalities of bone marrow-derived dendritic cells in systemic lupus erythematosus.

Authors:  Ying J Nie; Mo Y Mok; Godfrey C F Chan; Albert W Chan; O U Jin; Sushma Kavikondala; Albert K W Lie; Chak S Lau
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

Review 10.  Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.

Authors:  Jorge Schettini; Pinku Mukherjee
Journal:  Clin Dev Immunol       Date:  2009-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.